Inavolisib (GDC-0077, RG6114, RO-7113755) 是一种有效的 PI3K alpha (PI3Kα) 选择性抑制剂,IC50 为 0.038 nM。GDC-0077 对 PI3K α 的选择性比其他 I 类 PI3K 异构体(β、δ 和 γ)高 300 倍以上,对 PIK 家族成员的选择性高 2000 倍以上。GDC-0077 可与 PI3K 的 ATP 结合位点结合并抑制 PIP2 磷酸化为 PIP3。
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
GDC-0077
CAS number:2060571-02-8 molecular formula:C18H19F2N5O4
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | (S)-2-((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide | GDC0077 | GDC-0077 | INAVOLISIB [WHO-DD] | MS-26989 | AKOS040741785 | DB15275 | AMY16810 | Inavolisib [USAN] | O-Methyl Hydroxy | ||
| CAS number | 2060571-02-8 | molecular formula | C18H19F2N5O4 |
| molecular weight | 407.37 g/mol | Exact mass | - |
| PSA | 112.000 Ų | logp | 1.5 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS





